Skip to content

Rare Cardiac Genetic Variation Is Associated With Postoperative Atrial Fibrillation.

Sep 2026 · Circulation Genomic and Precision Medicine · pp. e005688 · 0 citations · 29 references
Medicine

TL;DR

Rare pathogenic/LP variants in cardiomyopathy genes were associated with risk of POAF and reduced AF-free survival over long-term follow-up across cardiac and noncardiac surgery.

Abstract

Background

New-onset postoperative atrial fibrillation (POAF) is a common surgical complication, yet the contribution of rare genetic variants to POAF is poorly characterized.

Methods

We conducted a cohort study including 49 913 adults who underwent surgery without a preoperative diagnosis of atrial fibrillation (AF). All participants had whole-genome sequencing linked to electronic health record data. Pathogenic or likely pathogenic (LP) variants were identified in 141 cardiac genes associated with early-onset AF. The primary outcome was POAF, defined as a new diagnosis of AF within 30 days of surgery; the secondary outcome was freedom from AF over 5 years. Multivariable regression and propensity-score matching were used to evaluate the associations between pathogenic/LP variants and POAF.

Results

Among 49 913 participants, 2298 underwent cardiac surgery and 47 615 underwent noncardiac surgery. The prevalence of pathogenic/LP variants was 6.0% in the cardiac surgery group (138/2298) and 4.1% in the noncardiac surgery group (1947/47 615). Overall, carriers of ≥1 pathogenic/LP variant had higher odds of POAF than noncarriers (6.6% versus 4.0%; odds ratio [OR], 1.8 [95% CI, 1.4-2.1]). In cardiac surgery, 36.0% of pathogenic/LP carriers (78/216) developed POAF versus 23.4% of noncarriers (492/2082; OR, 2.3 [95% CI, 1.4-3.2]), and in noncardiac surgery, POAF occurred in 3.8% of carriers (74/1947) versus 2.5% of noncarriers (1465/45 668; OR, 1.5 [95% CI, 1.2-1.9]). Pathogenic/LP variants in cardiomyopathy-only genes (n=589; OR, 1.8 [95% CI, 1.3-2.6]) or in genes associated with both cardiomyopathy and arrhythmia (n=1059; OR, 1.8 [95% CI, 1.4-2.3]) were significantly associated with POAF, whereas variants in arrhythmia-only genes (n=454; OR, 1.3 [95% CI, 0.8-2.1]) were not. Five-year freedom from AF was lower among pathogenic/LP variant carriers in both cardiac surgery (53% versus 64%; P=0.010) and noncardiac surgery (92% versus 94%; P=0.002).

Conclusions

Rare pathogenic/LP variants in cardiomyopathy genes were associated with risk of POAF and reduced AF-free survival over long-term follow-up across cardiac and noncardiac surgery.

View source

Similar papers

Sep 2026

Atrial Fibrillation in Genotyped Dilated Cardiomyopathy: Epidemiology, Risk Factors, and Outcomes: Insights From the SHaRe Registry.

BACKGROUND Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM) and is associated with adverse outcomes. However, the genetic determinants of AF risk and its prognostic significance across genotyped DCM subtypes remain unknown. METHODS In this observational cohort study, we analyzed...

I. Balakrishnan, A. Heymans, B. Claggett et al. · 0 citations
Sep 2026

Association between Genetic Variants of Uncertain Significance in Thoracic Aortic Disease and Outcomes Following Aortic Surgery.

BACKGROUND Genetic testing increasingly identifies variants of uncertain significance (VUS) in patients with thoracic aortic disease. Treated as benign, VUS impact on outcomes remains unclear. We evaluated associations between genetic variants and surgical outcomes in patients undergoing aortic surgery. METHODS This...

Sedem Dankwa, T. Phu, Ely Erez et al. · 0 citations
Review Open access Oct 2026

Genetic landscape of paediatric channelopathies and cardiomyopathies in Hong Kong.

INTRODUCTION Cardiac channelopathies and cardiomyopathies are important causes of sudden cardiac death. The genetic background of these conditions in Asian paediatric populations has rarely been reported. This study aimed to report the genetic underpinnings of these conditions in patients treated at a single tertiary p...

S.-Y. Kwok, H. Leung, J. Shi et al. · 0 citations
Review Open access Sep 2026

Comorbidity-modified biomarker prediction of postoperative atrial fibrillation after cardiac surgery: a scoping review

Postoperative atrial fibrillation (POAF) complicates 20–50% of cardiac surgical procedures and is associated with increased stroke risk, prolonged hospitalisation, and mortality. Numerous circulating and clinical biomarkers have been proposed for POAF risk stratification; however, diabetes, chronic kidney disease (CKD)...

O. Afolabi, M. Oluwajuyigbe, A. Adegbamigbe et al. · 0 citations
Sep 2026

Predictive Value of the HATCH Score for New-Onset Atrial Fibrillation Following TAVI.

BACKGROUND New-onset atrial fibrillation (NOAF) is a frequent complication after transcatheter aortic valve implantation (TAVI) and is associated with adverse outcomes, yet simple pre-procedural tools to identify at-risk patients are limited. The HATCH score predicts incident atrial fibrillation in other settings but h...

Ç. Tunca, Reha Yasin Şengül, Ahsen Özge Akpınar et al. · 0 citations
Open access Jul 2026

Phenotypic determinants of atrial fibrillation in ischaemic stroke: a retrospective study

Abstract Background Atrial fibrillation (AF) is a common cause of ischaemic stroke and a major global health burden, but is often undetected in routine clinical practice. Detection of AF is essential for secondary stroke prevention, but it remains unclear which patients who had a stroke are at highest risk of previousl...

Evi J. van Kempen, Wouter V. Elzinga, I. Olier et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.